| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | RMD Resmed Inc | Blaise Lucile | President, Sleep &Rc Business | Sell | 169 | $225.18 | $38,055.42 | -2.3% | -3.8% | -32.0% | |
| Nov 15, 2022 | TMCI Treace Medical Concepts, Inc. | Owens Daniel E.52 | Chief Human Resources Officer | Sell | 6,250 | $20.38 | $127,371.25 | -36.9% | +3.8% | -61.3% | |
| Nov 15, 2022 | BSX Boston Scientific Corp | Carruthers Wendy | EVP, Human Resources | Sell | 1,678 | $42.60 | $71,482.80 | -1.7% | +12.4% | +26.9% | |
| Nov 15, 2022 | RMD Resmed Inc | Farrell Michael J.63 | Chief Executive Officer | Sell | 5,675 | $224.64 | $1,274,837.11 | -1.4% | -3.8% | -32.0% | |
| Nov 15, 2022 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 4,551 | $3.63 | $16,520.13 | -0.4% | -14.0% | -93.4% | |
| Nov 15, 2022 | ENOV Enovis Corp | Pryor Daniel A74 | EVP, Strategy &Business Dev. | Sell | 67,421 | $54.58 | $3,679,568.50 | -47.1% | +14.8% | -7.2% | |
| Nov 15, 2022 | RMD Resmed Inc | Douglas Robert Andrew71 | President And COO | Sell | 11,280 | $222.07 | $2,504,939.45 | -21.9% | -3.8% | -32.0% | |
| Nov 15, 2022 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 14,483 | $60.13 | $870,862.79 | -3.3% | +18.3% | +14.0% | |
| Nov 15, 2022 | BLFS Biolife Solutions Inc | Duross Amy63 | Director | Sell | 2,600 | $24.35 | $63,310.00 | -12.5% | -7.1% | -49.8% | |
| Nov 15, 2022 | ICUI Icu Medical Inc/de | Sanzone Virginia Ruth64 | VP, General Counsel | Sell | 325 | $160.12 | $52,039.00 | -9.6% | +12.9% | -44.9% | |
| Nov 15, 2022 | PETV Petvivo Holdings, Inc. | Lai John | CEO And President | Buy | 3,000 | $2.36 | $7,070.12 | +0.2% | - | - | |
| Nov 15, 2022 | XRAY Dentsply Sirona Inc. | Lucier Gregory T45 | Director | Buy | 6,000 | $31.45 | $188,700.00 | +66.7% | +17.7% | -6.4% | |
| Nov 15, 2022 | BRKR Bruker Corp | Kastner Marc A60 | Director | Sell | 10,000 | $70.75 | $707,490.00 | -55.4% | +10.1% | -9.9% | |
| Nov 15, 2022 | TMCI Treace Medical Concepts, Inc. | Treace James T53 | Director | Sell | 50,000 | $20.29 | $1,014,692.47 | -1.2% | +3.8% | -61.3% | |
| Nov 15, 2022 | HOLX Hologic Inc | Thornal Kevin R | Group Pres, Global Diagnostics | Sell | 19,118 | $75.32 | $1,440,061.85 | -13.3% | +11.9% | -3.5% | |
| Nov 15, 2022 | MASS 908 Devices Inc. | Knopp Kevin J.79 | President And CEO | Sell | 20,000 | $11.04 | $220,759.36 | -1.4% | -1.3% | -38.2% | |
| Nov 15, 2022 | CATX Perspective Therapeutics, Inc. | Woods Lori A70 | CEO | Buy | 100,000 | $0.34 | $33,540.00 | +9.6% | +12.1% | -23.7% | |
| Nov 14, 2022 | SONX Sonendo, Inc. | Smith Michael John | Chief Commercial Officer | Sell | 7,341 | $1.92 | $14,093.99 | -2.1% | - | - | |
| Nov 14, 2022 | TMCI Treace Medical Concepts, Inc. | Scanlan Sean F.65 | SVP, Marketing | Sell | 25,000 | $24.27 | $606,680.00 | -71.5% | -11.6% | -69.8% | |
| Nov 14, 2022 | SONX Sonendo, Inc. | Watts Michael Patrick | Chief Financial Officer | Sell | 5,269 | $1.92 | $10,115.95 | -2.3% | - | - | |
| Nov 14, 2022 | SONX Sonendo, Inc. | Chen Roy T | Chief Talent Officer | Sell | 2,756 | $1.92 | $5,291.24 | -2.4% | - | - | |
| Nov 14, 2022 | MASI Masimo Corp | Kiani Joe E74 | CEO And Chairman Of The Board | Buy | 31,994 | $123.99 | $3,967,009.52 | +45.6% | +35.4% | -27.0% | |
| Nov 14, 2022 | AXGN Axogen, Inc. | Freitag Gregory Gene68 | Director | Sell | 13,000 | $12.74 | $165,620.00 | -3.7% | -26.9% | -54.0% | |
| Nov 14, 2022 | HYPR Hyperfine, Inc. | Rothberg Jonathan M71 | Director, 10% Owner | Buy | 34,488 | $0.89 | $30,694.32 | +6.3% | +32.3% | +36.0% | |
| Nov 14, 2022 | ECOR Electrocore, Inc. | Errico Joseph P59 | Director | Buy | 100,000 | $0.24 | $23,990.00 | +5.4% | +51.9% | +67.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.